Children's Oncology Group: Wilms Tumor trials
The registry lists 26 Wilms Tumor studies with Children's Oncology Group as lead sponsor. 2 are open to participants now and 7 have results posted.
Phase 1 1Phase 2 5Phase 3 6No phase 15(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid TumorsRecruitingNCT04851119Phase 1/2
- A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWTRecruitingNCT04322318Phase 2
- Lorvotuzumab Mertansine in Treating Younger Patients With Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial SarcomaCompletedNCT02452554Phase 2Results posted
- Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell TransplantCompletedNCT01305200Phase 3Results posted
- Combination Chemotherapy and Surgery in Treating Young Patients With Wilms TumorCompletedNCT00945009Phase 3Results posted
- Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' TumorCompletedNCT00379340Phase 3Results posted
- Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' TumorCompletedNCT00352534Phase 3Results posted
- Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney TumorsCompletedNCT00335556Phase 2Results posted
- Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell TransplantCompletedNCT00309907Phase 2Results posted
- Gene Analysis in Studying Susceptibility to Wilms TumorCompletedNCT01808079
- Studying Biomarkers in Urine Samples From Younger Patients With Wilms TumorCompletedNCT01614808
- Studying Genes Using Cord Blood and Placenta Samples From Relatively Healthy Newborns and Samples From Younger Patients With Wilms TumorCompletedNCT01576211
- Studying Biomarkers in Samples From Younger Patients With Wilms TumorCompletedNCT01576198
- Biomarkers in Urine Samples From Patients With Wilms TumorCompletedNCT01550393
- Studying Biomarkers in Samples From Younger Patients With Wilms TumorCompletedNCT01542333
- Biomarkers in Samples From Younger Patients With Wilms TumorCompletedNCT01493817
- Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing CancerCompletedNCT01353300
- Biomarkers in Blood and Tumor Tissue Samples From Patients With Wilms TumorCompletedNCT01314391
- Biomarkers in Tissue Samples From Patients With High-Risk Wilms TumorCompletedNCT01118078
- Biomarkers in Tumor Tissue Samples From Young Patients With Very Low Risk Wilms TumorsCompletedNCT01004783
- Study of Kidney Tumors in Younger PatientsCompletedNCT00898365
- Gene Expression Profiles to Categorize Wilms TumorsCompletedNCT00897637
- Evaluating Dactinomycin and Vincristine in Young Patients With CancerCompletedNCT00674193
- DNA Variations in the Gene in Young Patients With Wilms' TumorCompletedNCT00088803
- Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney CancerCompletedNCT00002611Phase 3
- Chemotherapy With or Without Surgery, Radiation Therapy, or Stem Cell Transplantation in Treating Young Patients With Kidney TumorsCompletedNCT00002610Phase 3